{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:23:11Z","timestamp":1790706191966,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1124\/dmd.123.001257","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T16:35:32Z","timestamp":1678898132000},"page":"782-791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine"],"prefix":"10.1016","volume":"51","author":[{"given":"J. Paige","family":"Barnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyun M.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor S.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caithlyne M.","family":"Guevarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaniya S.","family":"Pleasant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tri Q.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-6072","authenticated-orcid":false,"given":"Rachel D.","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.123.001257_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/dmd.118.085787","article-title":"Time Course of Aldehyde Oxidase and Why It Is Nonlinear","volume":"47","author":"Abbasi","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001257_bib2","doi-asserted-by":"crossref","first-page":"9469","DOI":"10.1021\/jo801053u","article-title":"Studies on the mechanism of aldehyde oxidase and xanthine oxidase","volume":"73","author":"Alfaro","year":"2008","journal-title":"J Org Chem"},{"key":"10.1124\/dmd.123.001257_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bcp.2018.03.002","article-title":"Identification of enzymes responsible for dantrolene metabolism in the human liver: A clue to uncover the cause of liver injury","volume":"151","author":"Amano","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.123.001257_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/dmd.112.048546","article-title":"Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase","volume":"41","author":"Barr","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001257_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1006\/abbi.1995.1320","article-title":"Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon","volume":"319","author":"Beedham","year":"1995","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.123.001257_bib6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nchembio.1895","article-title":"Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase","volume":"11","author":"Coelho","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1124\/dmd.123.001257_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/978-1-0716-1554-6_30","article-title":"Case Study 11: Considerations for Enzyme Mapping Experiments-Interaction between the Aldehyde Oxidase Inhibitor Hydralazine and Glutathione","volume":"2342","author":"Crouch","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.123.001257_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/dmd.109.030783","article-title":"Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differences","volume":"38","author":"Dalvie","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001257_bib9","first-page":"69","article-title":"Complexes of glutathione with heavy metals as catalysts for oxidation","volume":"99","author":"Dimitrova","year":"2010","journal-title":"React Kinet Mech Catal"},{"key":"10.1124\/dmd.123.001257_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/tx034170b","article-title":"Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development","volume":"17","author":"Evans","year":"2004","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.123.001257_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","article-title":"Glutathione: overview of its protective roles, measurement, and biosynthesis","volume":"30","author":"Forman","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.1124\/dmd.123.001257_bib12","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.115.068395","article-title":"Optimization of the Expression of Human Aldehyde Oxidase for Investigations of Single-Nucleotide Polymorphisms","volume":"44","author":"Foti","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001257_bib13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1124\/dmd.121.000549","article-title":"The Inactivation of Human Aldehyde Oxidase 1 by Hydrogen Peroxide and Superoxide","volume":"49","author":"Garrido","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001257_bib14","first-page":"1673","article-title":"Metabolism of hydralazine by activated leukocytes: implications for hydralazine induced lupus","volume":"18","author":"Hofstra","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1124\/dmd.123.001257_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0009-2797(93)90008-M","article-title":"Reactive intermediates in the oxidation of hydralazine by HOCl: the major oxidant generated by neutrophils","volume":"89","author":"Hofstra","year":"1993","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.123.001257_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/bdd.2123","article-title":"An iminium ion metabolite hampers the production of the pharmacologically active metabolite of a multikinase inhibitor KW-2449 in primates: irreversible inhibition of aldehyde oxidase and covalent binding with endogenous proteins","volume":"39","author":"Hosogi","year":"2018","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.123.001257_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/dmd.111.042861","article-title":"Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes","volume":"40","author":"Hutzler","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001257_bib18","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1016\/0006-2952(85)90280-1","article-title":"Hydralazine: a potent inhibitor of aldehyde oxidase activity in vitro and in vivo","volume":"34","author":"Johnson","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.123.001257_bib19","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/0006-2952(87)90549-1","article-title":"Metabolic activation of hydralazine by rat liver microsomes","volume":"36","author":"LaCagnin","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.123.001257_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0022-5347(24)07540-2","article-title":"Metabolism and disposition of hydralazine-14C in man and dog","volume":"2","author":"Lesser","year":"1974","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001257_bib21","doi-asserted-by":"crossref","first-page":"13025","DOI":"10.1021\/acs.jmedchem.1c01125","article-title":"Interrogating the Inhibition Mechanisms of Human Aldehyde Oxidase by X-Ray Crystallography and NMR Spectroscopy: The Raloxifene Case","volume":"64","author":"Mota","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.123.001257_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/dmd.32.1.89","article-title":"Potent inhibition of human liver aldehyde oxidase by raloxifene","volume":"32","author":"Obach","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001257_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0091270003260336","article-title":"Human liver aldehyde oxidase: inhibition by 239 drugs","volume":"44","author":"Obach","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.123.001257_bib24","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/jm100888d","article-title":"Aldehyde oxidase: an enzyme of emerging importance in drug discovery","volume":"53","author":"Pryde","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.123.001257_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1021\/tx960189l","article-title":"Peroxidase substrates stimulate the oxidation of hydralazine to metabolites which cause single-strand breaks in DNA","volume":"10","author":"Reilly","year":"1997","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.123.001257_bib26","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/0006-2952(95)02019-5","article-title":"Human liver oxidative metabolism of O6-benzylguanine","volume":"50","author":"Roy","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.123.001257_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0076-6879(95)49038-8","article-title":"Mechanism-based enzyme inactivators","volume":"249","author":"Silverman","year":"1995","journal-title":"Methods Enzymol"},{"key":"10.1124\/dmd.123.001257_bib28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0021-9258(18)33119-3","article-title":"Enzymatic activation of hydrazine derivatives. A spin-trapping study","volume":"258","author":"Sinha","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.123.001257_bib29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1021\/tx500011m","article-title":"DNA cleavage and detection of DNA radicals formed from hydralazine and copper (II) by ESR and immuno-spin trapping","volume":"27","author":"Sinha","year":"2014","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.123.001257_bib30","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0006-291X(82)91075-0","article-title":"Oxidative metabolism of hydralazine. Evidence for nitrogen centered radicals formation","volume":"105","author":"Sinha","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.123.001257_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0090-9556(25)08000-6","article-title":"Enzyme-mediated covalent binding of hydralazine to rat liver microsomes","volume":"11","author":"Streeter","year":"1983","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001257_bib32","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1124\/dmd.112.045195","article-title":"Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance","volume":"40","author":"Strelevitz","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001257_bib33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00204-016-1683-1","article-title":"Structure and function of mammalian aldehyde oxidases","volume":"90","author":"Terao","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.123.001257_bib34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0006-2952(91)90195-B","article-title":"Free radical production and site-specific DNA damage induced by hydralazine in the presence of metal ions or peroxidase\/hydrogen peroxide","volume":"41","author":"Yamamoto","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.123.001257_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/dmd.114.058750","article-title":"Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes","volume":"43","author":"Zientek","year":"2015","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562400998X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562400998X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.123.001257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:02:35Z","timestamp":1739955755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562400998X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S009095562400998X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.123.001257","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.123.001257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}